Adenoviral interleukin-3 gene-radiation therapy for prostate cancer in mouse model

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 2, 2004, Pages 579-583

  Oh, Young Taek ^a   Chen, Daniel W C ^b   Dougherty, Graeme J ^c   McBride, William H ^c  

^a Ajou University School of Medicine   (South Korea)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; Gene therapy; Interleukin 3; Prostate cancer; Radiation therapy

Indexed keywords

GENES; IRRADIATION; RADIOTHERAPY; TUMORS;

CANCER CELLS; GENE-RADIATION THERAPY;

ONCOLOGY;

ADENOVIRUS VECTOR; INTERLEUKIN 3; PROTEIN SUBUNIT; RADIOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; GENE THERAPY; INJECTION; IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOSENSITIZATION; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS TISSUE TUMOR;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; COMBINED MODALITY THERAPY; GENE THERAPY; GENETIC VECTORS; INTERLEUKIN-3; MALE; MICE; MICE, INBRED C57BL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 2442460017     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.01.030     Document Type: Article

References (26)

1. Gomez-Navarro J., Curiel D.T., Douglas J.T. Gene therapy for cancer. Eur J Cancer. 35:1999;2039-2057
2. Connell P.P., Weichselbaum R.R. Gene therapy The challenges of translating laboratory research into clinical practice. J Clin Oncol. 21:2003;2230-2231
3. McCormick F. Cancer gene therapy Fringe or cutting edge? Nat Rev Cancer. 1:2001;130-141
4. Galanis E., Russell S. Cancer gene therapy clinical trials Lessons for the future. Br J Cancer. 85:2001;1432-1436
5. Freytag S.O., Paielli D., Wing M., et al. Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model. Int J Radiat Oncol Biol Phys. 54:2002;873-885
6. Gallardo D., Drazan K.E., McBride W.H. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity. Cancer Res. 56:1996;4891-4893
7. Gorski D.H., Mauceri H.J., Salloum R.M., et al. Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy. Cancer Res. 63:2003;308-311
8. Lee C.G., Heijn M., di Tomaso E., et al. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res. 60:2000;5565-5570
9. Lee J., Moran J.P., Fenton B.M., et al. Alteration of tumour response to radiation by interleukin-2 gene transfer. Br J Cancer. 82:2000;937-944
10. Syljuasen R.G., Belldegrun A., Tso C.L., et al. Sensitization of renal carcinoma to radiation using alpha interferon (IFNA) gene transfection. Radiat Res. 148:1997;443-448
11. Caux C., Vanbervliet B., Massacrier C., et al. Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood. 87:1996;2376-2385
12. Eder M., Geissler G., Ganser A. IL-3 in the clinic. Stem Cells. 15:1997;327-333
13. Chiang C.S., Syljuasen R.G., Hong J.H., et al. Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo. Cancer Res. 57:1997;3899-3903
14. McBride W.H., Dougherty G.D., Wallis A.E., et al. Interleukin-3 in gene therapy of cancer. Folia Biol (Praha). 40:1994;62-73
15. Chiang C.S., Hong J.H., Wu Y.C., et al. Combining radiation therapy with interleukin-3 gene immunotherapy. Cancer Gene Ther. 7:2000;1172-1178
16. Salgaller M.L. Prostate cancer immunotherapy at the dawn of the new millennium. Expert Opin Investig Drugs. 9:2000;1217-1229
17. Ferrer F.A., Rodriguez R. Prostate cancer gene therapy. Hematol Oncol Clin North Am. 15:2001;497-508
18. Croyle M.A., Anderson D.J., Roessler B.J., et al. Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery. Pharm Dev Technol. 3:1998;365-372
19. Khuri F.R., Nemunaitis J., Ganly I., et al. a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med. 6:2000;879-885
20. Kouraklis G. Progress in cancer gene therapy. Acta Oncol. 38:1999;675-683
21. Pulaski B.A., McAdam A.J., Hutter E.K., et al. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res. 53:1993;2112-2117
22. Wu Y.Z., Hong J.H., Huang H.H., et al. Mechanisms mediating the effects of IL-3 gene expression on tumor growth. J Leukoc Biol. 68:2000;890-896
23. McBride W.H., Economou J.S., Kuber N., et al. Modification of tumor microenvironment by cytokine gene transfer. Acta Oncol. 34:1995;447-451
24. Cao X., Li Q., Ju D.W., Wang Q., et al. Enhanced antitumor effects of bone marrow transplantation in combination with fibroblast-mediated IL-2 and IL-3 gene therapy. Transplantation. 67:1999;1242-1250
25. Hillman G.G., Maughan R.L., Grignon D.J., et al. Neutron or photon irradiation for prostate tumors Enhancement of cytokine therapy in a metastatic tumor model. Clin Cancer Res. 7:2001;136-144
26. Hillman G.G., Xu M., Wang Y., et al. Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma. Hum Gene Ther. 14:2003;763-775